Results 21 to 30 of about 169,915 (161)
Evaluation of Association of Vitamin D Deficiency with Depression in Postmenopausal Women
, 2015 Objective: This study was aimed to investigate the association of depression with vitamin D deficiency in postmenopausal women. Materials and Methods: Postmenopausal women over 55 years who were independent in personal care and who could live ...
Gül Mete Civelek
core +1 more source
Differences in the What’s My M3? test between pre- and postmenopausal women [PDF]
, 2017 Aim of the study : To evaluate the differences in the What’s My M3 test between pre and postmenopausal women. Material and methods: Pre- and postmenopausal women who attended an endocrine gynaecology consultation were studied. In all them, the What’s
Sebastián Carranza-Lira +1 more
core +1 more source
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
, 2010 Bisphosphonates are the leading drugs for the treatment of osteoporosis. In randomized controlled trials (RCTs), alendronate, risedronate, and zoledronate have shown to reduce the risk of vertebral, nonvertebral, and hip fractures, whereas RCTs with ...
Graham Russell +8 more
core +1 more source
, 2012 PhDThe role of aromatase inhibitors (AIs) in breast cancer has expanded since their introduction in the mid-1990s. They are superior to tamoxifen in the treatment of postmenopausal women with oestrogen dependant tumours in the metastatic, neoadjuvant ...
Singh, Shalini
core
Emerging treatments for postmenopausal osteoporosis – focus on denosumab
, 2009 Piet GeusensDepartment of Internal Medicine, Subdivision of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands and Biomedical Research Institute, University Hasselt, BelgiumAbstract: The pathway of the receptor activator of ...
Piet Geusens
core +1 more source
Climacteric Lowers Plasma Levels of Platelet-Derived Microparticles: A Pilot Study in Pre-versus Postmenopausal Women [PDF]
, 2012 Background: Climacteric increases the risk of thrombotic events by alteration of plasmatic coagulation. Up to now, less is known about changes in platelet-(PMP) and endothelial cell-derived microparticles (EMP). Methods: In this prospective study, plasma
Erhard Hiller +12 more
core +1 more source
Whole-body vibration exercise in postmenopausal osteoporosis
, 2015 The report of the World Health Organization (WHO) of 2008 defines osteoporosis as a disease characterized by low bone mass and an increased risk of fracture.
Bartłomiej Niespodziński +3 more
core +1 more source
Bone Turnover in Postmenopausal Women with Bone Loss - Original Investigation
, 2005 Osteoporosis is characterized by decrease in bone strength due to decreased bone mass and disruption of bone microstructure and eventually increase in fracture risk.
Betül Kaya +4 more
core
Health behaviors of postmenopausal women
, 2014 Introduction: Health status and health-related quality of life of postmenopausal women are issues, which nowadays pose a serious challenge to many domains of science.
Katarzyna Żułtak-Bączkowska +6 more
core +1 more source
Hysteroscopy in postmenopausal bleeding
Journal of Gynecological Endoscopy and Surgery, 2009 1) To study the etiology of postmenopausal bleeding (PMB). 2) To study the significance of hysteroscopy in evaluation of the etiopathogenic factors. 3) Correlating the diagnosis after transvaginal sonography (TVS), hysteroscopy and histopathologic diagnosis.
Tandulwadkar, Sunita +3 more
openaire +3 more sources